Status:
COMPLETED
A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo
Lead Sponsor:
Watson Pharmaceuticals
Conditions:
Overactive Bladder
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A new drug for overactive bladder is compared to placebo to determine if it is safe and effective. The study lasts approximately 12 weeks.
Eligibility Criteria
Inclusion
- Females and males, 18 years of older with overactive bladder symptoms
Exclusion
- Treatable conditions that may cause urinary incontinence
- Medical conditions in which it would be unsafe to use an anti-cholinergic agent.
- The use of concomitant drugs that would confound the efficacy evaluation.
- The use of concomitant drugs that would be unsafe with an anti-cholinergic agent.
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
789 Patients enrolled
Trial Details
Trial ID
NCT00350636
Start Date
June 1 2006
End Date
May 1 2007
Last Update
May 10 2010
Active Locations (63)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States
2
Homewood, Alabama, United States
3
Mobile, Alabama, United States
4
Montgomery, Alabama, United States